Global alternative asset manager The Carlyle Group (NASDAQ:CG)
today announced that Dr. Martin D. Madaus will become Chairman and Chief
Executive Officer of Ortho-Clinical Diagnostics (“OCD”) subject to the
close of Carlyle’s acquisition of OCD from Johnson & Johnson, which is
expected in mid-2014. Eric Compton, OCD Worldwide President, will
continue with the company following the close of the transaction.
Introduced to OCD today during a global employee meeting, Dr. Madaus
said, “I am pleased by the opportunity to join Ortho-Clinical
Diagnostics and look forward to working with such a talented group of
professionals around the world. I am excited at the prospect of leading
the organization through its next phase of growth, driven by new product
innovation and geographic expansion. Eric and his team have accomplished
great things as part of Johnson & Johnson and I look forward to helping
transform OCD into a global diagnostics leader as a standalone entity.”
Eric Compton, OCD Worldwide President, said, “OCD has made strategic
investments in research and development programs over the past few years
and the Company is poised for continued success in the future. Together
with Martin and the team at Carlyle, we believe OCD is positioned to
accelerate growth globally through new product introductions.”
Stephen H. Wise, Carlyle Managing Director, said, “As an experienced
executive with an exemplary track record of growing businesses, Martin
can lead OCD through its transition to an independent company and
transformation into a leading diagnostics platform. We believe our
long-term partnership with Martin in the in vitro diagnostics industry
will create significant value for our investors over the coming years.”
Dr. Madaus is the current Executive Chairman of Quanterix’s Board of
Directors. He most recently served as President, Chairman and Chief
Executive Officer of Millipore Corp., which was acquired by Merck KGaA
in 2010. Before joining Millipore, Dr. Madaus was President, Chief
Executive Officer and Head of North American Operations for Roche
Diagnostics Corp.
He also held a number of senior-level sales, marketing and product
management positions with Boehringer Mannheim Corp. in both Germany and
the United States. In addition to Quanterix, Dr. Madaus is a director at
Carlyle portfolio company PPD, Mettler Toledo, and Covidien. He has a
doctor of veterinary medicine degree from the University of Munich,
Germany and a doctorate in veterinary medicine from the Veterinary
School of Hanover, Germany.
The close of the transaction is subject to the fulfillment of certain
conditions, including the receipt of applicable anti-trust clearances
and other customary closing requirements.
About Ortho-Clinical Diagnostics, Inc.
Ortho-Clinical Diagnostics, Inc. delivers the high-quality in vitro
diagnostic products that give healthcare professionals around the world
the knowledge they need to make better treatment decisions sooner. The
company serves the global transfusion medicine community with donor
screening and blood typing products to help ensure every patient
receives blood that is safe, the right type and the right unit.
Ortho-Clinical Diagnostics also brings sophisticated information
management, testing technologies and automation and interpretation tools
to clinical laboratories worldwide to help them run more efficiently and
improve patient care. For more information, visit www.orthoclinical.com
About The Carlyle Group
The Carlyle Group (NASDAQ: CG) is a global alternative asset manager
with approximately $189 billion of assets under management across 118
funds and 100 fund of funds vehicles as of December 31, 2013. Carlyle's
purpose is to invest wisely and create value on behalf of its investors,
many of whom are public pensions. Carlyle invests across four segments –
Corporate Private Equity, Real Assets, Global Market Strategies and
Solutions – in Africa, Asia, Australia, Europe, the Middle East, North
America and South America. Carlyle has expertise in various industries,
including: aerospace, defense & government services, consumer & retail,
energy, financial services, healthcare, industrial, real estate,
technology & business services, telecommunications & media and
transportation. The Carlyle Group employs more than 1,500 people in 34
offices across six continents.
Web: www.carlyle.com
Videos:
www.youtube.com/onecarlyle
Tweets:
www.twitter.com/onecarlyle
Podcasts:
www.carlyle.com/about-carlyle/market-commentary
Copyright Business Wire 2014